Recalls / Active ingredient / Nivolumab
Nivolumab
1 FDA drug recall involving the active ingredient “Nivolumab”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-10-21 | Class II | Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, | Bristol-Myers Squibb Company |